Breast Cancer Infiltrates and Immune Response
Author Information
Author(s): D.J. Rowe, P.C.L. Beverley
Primary Institution: I.C.R.F. Human Tumour Immunology Group, School of Medicine, University College London
Hypothesis
Can the characterization of breast cancer infiltrates using monoclonal antibodies provide prognostic information?
Conclusion
The study found that malignant breast tumors had more infiltrating leucocytes than benign conditions, but the T cells present were not always activated.
Supporting Evidence
- More infiltrating leucocytes were seen in malignant breast tumor sections compared to benign conditions.
- A considerable proportion of the infiltrating cells were T cells, with more suppressor/cytotoxic T cells than helper/inducer T cells.
- Malignant tumor cells were generally negative or weakly positive for HLA staining.
Takeaway
This study looked at how the immune cells in breast cancer are different from those in benign conditions, finding that cancer has more immune cells, but they might not be working properly.
Methodology
The study used indirect immunoperoxidase staining on frozen sections from patients with malignant and benign breast conditions.
Limitations
The study had a small sample size and did not provide definitive prognostic information.
Participant Demographics
Patients aged 28-66, with 11 having malignant breast tumors and 6 having benign conditions.
Want to read the original?
Access the complete publication on the publisher's website